Dr. Sandeep Nayak: Game-changer in Cancer Care

Sandeep Nayak,  Chief of Surgical Oncology

Sandeep Nayak

Chief of Surgical Oncology

In a world where statistics show a grim picture of cancer incidence, Dr. Sandeep Nayak stands as a hope with his innovations in cancer treatments. He always ponders for innovation to push the boundaries of cancer care. There is ethics and empathy in all his deeds. And his professional life can be summed up in a clear vision: to make cancer surgery less invasive, more effective, and equally accessible to all.

Dr. Nayaks journey in healthcare began with his pursuit of a medical degree at Kasturba Medical College. He did his post-graduation in general surgery at Government Medical College, Calicut. He also pursued a doctoral degree in surgical oncology at the prestigious Chittaranjan National Cancer Institute in Kolkata, and obtained a Fellowship in Laparoscopic and Robotic Onco-Surgery.

Dr. Sandeep Nayak holds the prestigious positions of Director and Head of the Department of Surgical Oncology at Fortis Hospital, Bangalore, and Chief of Surgical Oncology at Macs Clinic, Bangalore, showcasing his leadership and expertise in the field of oncology.

Revolutionizing Treatments
His dedication to advancing cancer treatment techniques has led to the introduction of cutting-edge procedures that have redefined cancer surgery in India. Among his groundbreaking contributions are award winning RIA- MIND for oral, head, and neck cancers and RABIT for thyroid cancer, which have received prestigious accolades such as the KS International award and more. Additionally, he has introduced Minimally Invasive Neck Dissection (MIND) for mouth
cancer and Lateral Approach Modified Video Endoscopic Inguinal Lymphadenectomy (VEIL)

for groin node cancer. Furthermore, his exceptional success in performing highest number of sphincter preservation surgeries for rectal cancer has made a profound impact, sparing patients from permanent stomas and enhancing their post-surgery quality of life. These innovations represent a new dawn in cancer surgery, offering patients less invasive and more precise treatment options.

His specialization covers a wide spectrum, encompassing Head and Neck Tumors, Abdominal Organs, Digestive Tract Cancers, Chest Tumors, Urinary Tract Cancers, Colorectal Cancer, and Gynecologic cancer. Patients from all corners of India and even abroad seek his expertise for several intricate procedures, especially head & neck and rectum surgeries.

Targeting DNA changes in cancer treatment is like disrupting the disease at its very core, offering hope & better success rates

The Evolving Healthcare Infrastructure That is Need of Skills
As one of the best oncologists and a prominent healthcare professional in Bangalore, Dr. Nayak has borne witness to the transformation of the healthcare landscape in the city. While there has been significant growth in the number of healthcare institutions and the adoption of advanced technologies, he highlights the critical importance of focusing on skill-building among healthcare providers. Dr. Nayak believes that skill and knowledge should take precedence over the construction of buildings, emphasizing the need for highly skilled professionals to provide quality care.

He also recognizes that ethical practice is a challenge in the modern healthcare landscape and asserts that it is essential for delivering quality care.

The Rising Challenge & Future of Oncology
Dr. Nayak shares, “Cancer rates are increasing due to the aging demographic and the chronic nature of the disease. In simple words, cancer is a result of wear and tear, as we age the DNA is more likely to change. If we don’t take care of ourselves well, the changes will occur much sooner. Individuals should take charge of their health and maintain their bodies, as prevention and early intervention are key in the fight against cancer”.

He further mentions, “Over the past decade, the field of oncology has witnessed remarkable innovations the integration of technology, precision oncology, and advances in surgical techniques. We can soon see treatments tailored based on DNA damage rather than cancer origin, marking a significant shift in cancer care”.